Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
| Year |
Award Type |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
|---|---|---|---|---|---|---|---|
| 2015 | R43 | CA193134 | PAR-13-327 | NEVO, EREZ | ROBIN MEDICAL, INC. | COMBINED OPTICAL AND MR MICROSCOPY SYSTEM FOR THIN TISSUE HISTOPATHOLOGY ANALYSIS | Complete |
| 2002 | R43 | CA091380 | PAR-99-101 | SHEFER, RUTH E | NEWTON SCIENTIFIC, INC. | A LASER-ACTIVATED REACTOR FOR BIOMEDICAL C-14-AMS | Complete |
| 2015 | R43 | CA199055 | PAR-13-327 | MCCONNELL, TIMOTHY S | ISOPLEXIS, INC. | A SINGLE CELL MULTI-PROTEIN DEVICE TO FACILITATE CANCER IMMUNOTHERAPY | Complete |
| 1999 | R43 | CA081835 | PAR-98-066 | MOSTERT, MICHAEL J | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |
| 2001 | R43 | CA089782 | PAR-99-101 | PICCOLI, STEVEN P | MOLECULAR STAGING, INC. | ROLLING CIRCLE AMPLIFICATION ANALYSIS OF CERVICAL CELLS | Complete |
| 2020 | R43 | CA243757 | PAR-18-303 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC. | N6-Methyl-2-O-Methyladenosine Sequencing | Active |
| 2002 | R43 | CA094361 | PAR-99-101 | HENKENS, ROBERT W | ALDERON BIOSCIENCES, INC. | INNOVATIVE TECHNOLOGY FOR GENE EXPRESSION STUDIES | Complete |
| 2015 | R43 | CA199058 | PAR-13-327 | SARAF, RAVI | VAJRA INSTRUMENTS, INC. | PROFILING CIRCULATING MIRNA WITHOUT PCR FOR EARLY DETECTION OF PANCREATIC CANCER | Complete |
| 1999 | R43 | CA081860 | PAR-98-066 | CHANG, HWAI W | STRATAGENE | GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES | Complete |
| 2001 | R43 | CA091423 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | SELECTION OF THE BEST LIGANDS FROM COMBINATORIAL LIBRARY | Complete |
| 2016 | R43 | CA203671 | PAR-13-327 | OUELLETTE, STEVEN BRADLEY | KINASENSE, LLC | DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY | Complete |
| 2002 | R43 | CA094404 | PAR-01-105 | MARTIN, MARK | MIRARI BIOSCIENCES, INC. | MICROWAVE-ENHANCED LUMINESCENCE TO DETECT GROWTH FACTORS | Complete |
| 2015 | R43 | CA199142 | PAR-13-327 | ORBAI, LUCIAN | CELL DATA SCIENCES, INC. | RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS | Complete |
| 1999 | R43 | CA081870 | PAR-98-066 | MILLER, JEFFREY E. | IVS TECHNOLOGIES, LLC | NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS | Complete |
| 2001 | R43 | CA092796 | PAR-99-101 | SHEN, SHANXIANG | PROTIVERIS, INC. | MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING | Complete |
| 2016 | R43 | CA203675 | PAR-13-327 | KLUGE, JONATHAN AUGUST | VAXESS TECHNOLOGIES, INC. | SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS | Complete |
| 2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
| 2002 | R43 | CA096051 | PAR-01-105 | FENG, LI | ECHELON BIOSCIENCES, INC. | LIPID MICROARRAYS | Complete |
| 2015 | R43 | CA199152 | PAR-13-327 | EASTBURN, DENNIS J | MISSION BIO, INC. | MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING | Complete |
| 1999 | R43 | CA081890 | PAR-98-066 | NERI, BRUCE P | THIRD WAVE TECHNOLOGIES, INC. | SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION | Complete |
| 2001 | R43 | CA092819 | PAR-99-101 | WANG, PENCHENG | CALIBRANT BIOSYSTEMS, INC. | 2-D MICROFLUIDIC GENE SCANNER | Complete |
| 2004 | R43 | CA105536 | PAR-01-105 | BECKER, CHRISTOPHER H | SURROMED, INC. | DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME | Complete |
| 2016 | R43 | CA203629 | PAR-13-327 | GUNDERSON, KEVIN L | ENCODIA, INC. | Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer | Complete |
| 2002 | R43 | CA096052 | PAR-01-105 | ISRAEL, BARBARA A. | PLATYPUS TECHNOLOGIES, LLC | OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS | Complete |
| 2015 | R43 | CA199211 | PAR-13-327 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE | Complete |
| 1999 | R43 | CA081891 | PAR-98-066 | WEAVER, DANIEL C | GENOMICA CORPORATION | ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY | Complete |
| 2001 | R43 | CA092826 | PAR-99-101 | WANG, JIWU | ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS | INNOVATIVE RNA PROFILING IN CANCER CELLS | Complete |
| 2004 | R43 | CA105540 | PAR-01-105 | NIELSEN, ULRIK B. | MERRIMACK PHARMACEUTICALS, INC. | PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS | Complete |
| 2016 | R43 | CA203647 | PAR-13-327 | LIM, MARK | AMBERGEN, INC | Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays | Complete |
| 2002 | R43 | CA096053 | PAR-01-105 | BECKER, CHRISTOPHER | SURROMED, INC. | AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING | Complete |
| 1999 | R43 | CA081903 | PAR-98-066 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD | Complete |
| 2001 | R43 | CA093155 | PAR-99-101 | JOHNSON, PAUL H | EPIGENX PHARMACEUTICALS | WHOLE GENOME METHYLATION ASSAY | Complete |
| 2004 | R43 | CA105542 | PAR-01-105 | PARIS, MARK J | VACCINEX, INC. | FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS | Complete |
| 2016 | R43 | CA203681 | PAR-13-327 | KING, JEFFREY S | VIROGENOMICS BIODEVELOPMENT, INC. | Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia | Complete |
| 2000 | R43 | CA081787 | PAR-99-101 | BUTT, TAUSEEF R. | LIFESENSORS, INC. | LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER | Complete |
| 2002 | R43 | CA096056 | PAR-01-105 | STRAUME, TORE | GENMETRIX, LLC | ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES | Complete |
| 1999 | R43 | CA081949 | PAR-98-066 | OLINER, JONATHAN D | AFFYMETRIX, INC. | REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS | Complete |
| 2001 | R43 | HL069675 | PAR-99-101 | WILLETT, CATHERINE E | PHYLONIX PHARMACEUTICALS, INC. | ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS | Complete |
| 2004 | R43 | CA107764 | PAR-01-105 | VYKOUKAL, JODY V | ADEPTAS, INC. | RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY | Complete |
| 2000 | R43 | CA084678 | PAR-98-066 | BAMDAD, CYNTHIA C. | MINERVA BIOTECHNOLOGIES CORPORATION | RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS | Complete |
| 2002 | R43 | CA096059 | PAR-01-105 | LOGE, GARY | SPECTRUMEDIX CORPORATION | AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM | Complete |
| 1999 | R43 | CA081951 | PAR-98-066 | XANTHOPOULOS, KLEANTHIS G | AURORA BIOSCIENCES CORPORATION | ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS | Complete |
| 2001 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 2004 | R43 | CA108005 | PAR-01-105 | HEILIG, JOSEPH S | SOMALOGIC, INC. | APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT | Complete |
| 2003 | R43 | CA099111 | PAR-01-105 | SHEN, LI | SUPERARRAY BIOSCIENCE CORPORATION | ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT | Complete |
| 2000 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
| 2002 | R43 | CA096065 | PAR-01-105 | GAU, VINCENT JEN-JR | GENEFLUIDICS, INC. | RAPID MOLECULAR DETECTION OF PML/RARALPHA | Complete |
| 1999 | R43 | CA081952 | PAR-98-066 | CHEE, MARK S. | ILLUMINA, INC. | GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS | Complete |
| 2003 | R43 | CA101271 | PAR-01-105 | DIATCHENKO, LUDA | ATTAGENE, INC. | PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER | Complete |
| 2009 | R43 | CA137737 | RFA-CA-08-011 | ZWICK, MICHAEL G | ANDROBIOSYS, INC. | PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU | Complete |